REACH Regulation Cost Accounting for Indian Specialty Chemical Exporter to EU

A Tier-1 Indian fluoro-intermediate specialty chemistry producer closes its books for the financial year ending 31 March 2027. The producer exports a portfolio of six fluoro-intermediate substances — three refrigerant intermediates (R-32, R-125 and R-134a chemistry precursors) and three agrochemical intermediates — from its Dahej PCPIR (Gujarat) and Bhiwadi (Rajasthan) manufacturing plants to European Union customers, at an aggregate EU export revenue of EUR 40 to 60 million per year. Every substance in the portfolio is registered with the European Chemicals Agency (ECHA) in Helsinki under EU Regulation (EC) No 1907/2006 — REACH — via an Only Representative established in the Netherlands, appointed under Article 8 of REACH. The per-substance REACH registration cost — Only Representative retainer, SIEF fee, consortium Letter of Access, and ECHA tonnage-band registration fee — is capitalised as an identifiable intangible asset under Ind AS 38 and carried in the intangible-asset register with either a 10 to 15 year finite-useful-life amortisation profile aligned with the periodic dossier review cycle under REACH Article 25, or an indefinite useful life with annual impairment testing under Ind AS 36. The annual OR retainer remittance is a FEMA import of services under Form A2 through an Authorised Dealer bank; Section 195 TDS applies with DTAA treaty relief typically available; any Indian regulatory-consulting support engaged locally falls under Section 194J with new payment code 1005 and reconciles to Form 26AS. The reconciliation discipline that anchors the CFO’s annual REACH cost accounting packet, defensible at the statutory audit and the Board’s EU-market compliance review, is the subject of this REACH regulation cost accounting Indian specialty chemical exporter EU cornerstone.

Quick reference

The reconciliation in one paragraph

An Indian specialty chemistry producer exporting substances to the European Union in quantities of one tonne or more per year per substance must register each substance with ECHA under REACH via an Only Representative appointed under Article 8. The per-substance REACH registration cost aggregates four components: the annual OR retainer (EUR 8,000 to 12,000 per year per substance), the one-time SIEF fee (EUR 5,000 to 15,000 per substance), the one-time consortium Letter of Access to the shared registration dossier (EUR 30,000 to 80,000 per substance), and the one-time ECHA tonnage-band registration fee (EUR 1,700 to EUR 33,000 depending on the tonnage band). The one-time components are capitalised as an identifiable intangible asset under Ind AS 38 paragraph 21, with the useful life determination under paragraph 88 either finite (10 to 15 years amortised on a straight-line basis, matching the periodic dossier review cycle under REACH Article 25 and the substance commercial life) or indefinite (no amortisation, annual impairment testing under Ind AS 36 paragraph 10). The annual OR retainer flows either as opex or as directly attributable cost added to the intangible asset carrying value per the enterprise’s accounting policy. The remittance of OR retainer, SIEF fee, LoA fee and ECHA fee to EU-established entities is a FEMA import of services under Form A2 through an Authorised Dealer bank with Section 195 TDS analysis and DTAA treaty relief documented via Tax Residency Certificate, Form 10F and Form 15CA / 15CB. Section 194J with new payment code 1005 applies to Indian regulatory-consulting support engaged locally, reconciled to Form 26AS. The annual reconciliation packet aggregates the per-substance registration cost register, the Ind AS 38 intangible asset register with useful life determination and amortisation schedule, the Ind AS 36 impairment test log, the FEMA remittance record, the Section 195 and Section 194J TDS records, the SVHC monitoring log with any Article 33 supply-chain notifications, and the substance-level export volume and revenue register reconciled to the tonnage-band ceiling.

What the scenario looks like in India — a Dahej PCPIR plus Bhiwadi fluoro-intermediate exporter persona

The illustrative persona for this walkthrough is a Tier-1 Indian fluoro-intermediate specialty chemistry producer with primary manufacturing plants at Dahej PCPIR (the Petroleum, Chemicals and Petrochemicals Investment Region on the Gulf of Khambhat, Gujarat) and Bhiwadi (Rajasthan). The producer’s fluoro-intermediate portfolio spans two commercial sub-cluster segments — refrigerant intermediates that feed the global HFC (hydrofluorocarbon) supply chain (chemistry precursors for R-32, R-125 and R-134a), and agrochemical intermediates that feed the global crop-protection active-ingredient supply chain. The aggregate EU export revenue across the six substance portfolio is in the illustrative EUR 40 to 60 million per year range, with individual substance exports ranging from 50 to 400 tonnes per year per substance depending on the substance’s downstream demand profile and the producer’s market share in the European Union.

Illustrative Tier-1 Indian specialty chemistry producers with strong fluoro-intermediate portfolios and material EU export exposure include SRF Ltd (Gurugram-headquartered, Dahej plus Bhiwadi manufacturing base, chemicals-plus-technical-textiles-plus-packaging-films business mix with fluoro-chemistry at the technology core), Navin Fluorine International (Mumbai-headquartered, Surat plant plus Dahej greenfield expansion, refrigerant plus specialty chemicals plus contract-development-and-manufacturing services), and Gujarat Fluorochemicals GFL (Noida-headquartered, Ranjitnagar plant, refrigerant plus fluoropolymer plus fluorospecialty chemicals). Each producer runs an Only Representative appointment for its EU-registered substance portfolio, typically with a specialist regulatory-consulting firm in the Netherlands, Germany, Ireland or Belgium acting as OR. The reconciliation discipline for the per-substance REACH registration cost, the Ind AS 38 intangible asset register and the annual amortisation-and-impairment cycle is uniform across the three producers, though the specific substance portfolio and the aggregate registration cost quantum differ producer by producer.

Adjacent Indian specialty chemistry producers exporting to the EU with different substance portfolios but the same REACH mechanic — Aarti Industries (Mumbai-headquartered, Vapi and Tarapur benzene-intermediates plus complex-molecule agrochem intermediates), UPL Ltd (Mumbai-headquartered, global crop-protection formulator with active-ingredient exports to EU), PI Industries (Udaipur-headquartered, agrochem CSM contract-manufacturing-with-multinationals), Deepak Nitrite (Vadodara-headquartered, phenol-acetone-plus-DASDA-plus-nitration flagship), Vinati Organics (Mumbai-headquartered, isobutylbenzene and ATBS global-leadership positions), Anupam Rasayan (Surat-headquartered, life-sciences custom synthesis) and Camlin Fine Sciences (Mumbai-headquartered, food-grade antioxidants including TBHQ and BHT) — each run the same REACH registration cost accounting discipline for their respective EU-registered substance portfolios.

The regulatory overlay — REACH Regulation (EC) No 1907/2006, Ind AS 38, Ind AS 36, Section 195 and Section 194J

Five regulatory anchors govern an Indian specialty chemistry producer’s REACH cost accounting surface. REACH Regulation (EC) No 1907/2006 is the EU chemicals framework; Ind AS 38 governs the intangible asset accounting; Ind AS 36 governs the impairment testing; Section 195 of the Income-tax Act 1961 governs the TDS on the OR retainer remittance; and Section 194J of the Income-tax Act 1961 governs the TDS on Indian consultancy support.

REACH — Registration, Evaluation, Authorisation and Restriction of Chemicals — is EU Regulation (EC) No 1907/2006, in force since 1 June 2007 and administered by ECHA in Helsinki. Article 3(9) defines a manufacturer as any natural or legal person established within the Community who manufactures a substance within the Community. A non-EU manufacturer such as an Indian specialty chemistry producer cannot register directly. Article 8 permits the non-EU manufacturer to appoint a natural or legal person established within the Community — an Only Representative — to carry out the registration obligations on the non-EU manufacturer’s behalf; the OR takes on the responsibility of a registrant, maintains the registration dossier, holds the substance-safety data, coordinates with the SIEF of all registrants of the same substance, and handles all correspondence with ECHA. Article 6 requires registration of any substance manufactured in or imported into the Community in quantities of one tonne or more per year per registrant. The tonnage-band system determines the registration fee and the data requirements. Article 11 requires joint submission of data by all registrants of the same substance through the SIEF, with cost-sharing coordinated via a consortium and access to the shared registration dossier granted via a Letter of Access. Article 25 requires periodic review and update of the registration dossier. Article 33 requires supply-chain notification of Substances of Very High Concern present above 0.1 percent weight by weight in articles.

Ind AS 38 governs the accounting treatment of intangible assets. Paragraph 8 defines an intangible asset as an identifiable non-monetary asset without physical substance. Paragraph 12 defines identifiability — separability, or arising from contractual or other legal rights. A REACH registration meets the identifiability test because it arises from contractual and legal rights (the OR appointment, the SIEF consortium participation, the ECHA registration certificate) and is separable in principle from the underlying substance-manufacturing business. Paragraph 21 establishes the recognition criteria — probable future economic benefits attributable to the asset and reliable measurement of cost. Paragraph 88 requires classification of useful life as finite or indefinite; paragraph 97 requires amortisation over the finite useful life; paragraph 107 requires an intangible asset with indefinite useful life to be tested for impairment annually and whenever there is an indication of impairment; paragraph 109 requires review of the useful life assessment each period.

Ind AS 36 governs impairment testing. Paragraph 10 requires annual impairment testing of intangible assets with indefinite useful life. Paragraph 12 lists impairment indicators — external indicators include adverse changes in market or regulatory environment; internal indicators include evidence of asset performance below expectation. For a REACH-registered substance, a material and sustained decline in EU export volume, an SVHC candidate list addition affecting the substance, or an Annex XVII Restriction proposal each qualify as impairment indicators requiring an impairment test.

Section 195 of the Income-tax Act 1961 requires deduction of tax at source on payments to non-residents chargeable to tax in India. The taxability depends on the DTAA between India and the OR’s country of establishment; the OR retainer may be classified as business profits (Article 7) or as fees for technical services (Article 12) depending on the treaty language and the make-available test. Section 194J with new payment code 1005 (Fees for Professional or Technical Services) applies to Indian consultancy support engaged locally for the REACH programme, reconciled to Form 26AS.

The FEMA Current Account Transactions Rules 2000 and the RBI Master Direction on Import of Goods and Services govern the remittance mechanics — Form A2 through an Authorised Dealer bank with Form 15CA / 15CB certificate for remittances above the notified threshold.

A worked example — a Dahej PCPIR plus Bhiwadi fluoro-intermediate exporter at year end 31 March 2027

Illustrative — the following figures represent the operating pattern of a Tier-1 Indian fluoro-intermediate specialty chemistry producer with plants at Dahej PCPIR and Bhiwadi and EU export revenue in the EUR 40 to 60 million per year range. Public disclosures by listed Indian fluoro-chemistry majors do not reveal per-substance REACH registration cost quantum in the granularity below; cross-verify against your own REACH registration cost register and Ind AS 38 intangible asset register before action.

The producer’s six-substance EU-registered portfolio closes the financial year 31 March 2027 with the following REACH registration cost profile and Ind AS 38 carrying value position (all EUR):

The aggregate one-time registration cost across the six substances is EUR 478,000 (approximately Rs 4.3 crore at Rs 90 per EUR). The aggregate annual OR retainer is EUR 60,000 per year (approximately Rs 54 lakh per year). The producer’s Ind AS 38 intangible asset register carries the aggregate one-time cost as the initial recognition value of the six-substance REACH registration bundle, with each substance carried as a separately identifiable line item.

The producer’s useful life determination is a mixed profile. The three refrigerant intermediates carry the finite 15-year amortisation treatment — the substance commercial life is aligned with the global HFC phase-down trajectory under the Kigali Amendment to the Montreal Protocol; the periodic dossier review cycle under REACH Article 25 is expected to require material dossier updates within the 10 to 15 year horizon; and the enterprise’s conservative capital-preservation policy favours amortisation over indefinite treatment. The three agrochemical intermediates carry the finite 10-year amortisation treatment — the substance commercial life is aligned with typical agrochemical active-ingredient market cycles, the annual straight-line amortisation for the R-32, R-125 and R-134a substances is EUR 95,000 / 15 = EUR 6,333; EUR 92,000 / 15 = EUR 6,133; and EUR 102,000 / 15 = EUR 6,800 respectively. The annual straight-line amortisation for the three agrochemical substances is EUR 63,000 / 10 = EUR 6,300; EUR 58,000 / 10 = EUR 5,800; and EUR 68,000 / 10 = EUR 6,800 respectively. Aggregate annual amortisation charge is EUR 38,166 (approximately Rs 34.3 lakh per year at Rs 90 per EUR).

The annual impairment indicator assessment per Ind AS 36 paragraph 12 flags one substance — Agrochem Intermediate B — for detailed impairment testing because the substance-specific EU export volume declined from 78 tonnes in FY 2025-26 to 55 tonnes in FY 2026-27, a 29 percent decline attributable to a downstream EU agrochemical formulator’s product-portfolio rationalisation. The recoverable amount computation under Ind AS 36 (the higher of fair value less costs of disposal and value in use) supports the current carrying value net of accumulated amortisation, and no impairment charge is recognised, but the observation is captured in the annual impairment test log and the substance is flagged for follow-up in FY 2027-28.

The annual OR retainer remittance of EUR 60,000 (approximately Rs 54 lakh per year) to the Netherlands-based Only Representative is processed as an import of services under Form A2 through the Authorised Dealer bank. The OR is a Netherlands tax resident with a valid Tax Residency Certificate on file; the retainer is analysed under Article 7 (business profits) of the India-Netherlands DTAA and Article 12 (fees for technical services) with the make-available test. The Chartered Accountant issues a Form 15CB supporting the nil-TDS position under the make-available test, and Form 15CA is filed with the tax authority before remittance. Local Indian regulatory-consulting support engaged during the year — a Mumbai-based regulatory-consulting firm providing SVHC monitoring liaison and dossier-update coordination at an annual retainer of Rs 12 lakh — attracts Section 194J TDS at the standard rate with new payment code 1005, reconciling to Form 26AS in the quarterly TDS return.

The annual SVHC monitoring log tracks the two 2026 ECHA candidate list updates (June 2026 and December 2026) and confirms that none of the six portfolio substances or their constituent components crossed the 0.1 percent weight by weight SVHC threshold; no Article 33 supply-chain notification is triggered during the year. The substance-level export volume and revenue register confirms all six substances remain within their current tonnage-band ceiling for the year, though the R-134a chemistry precursor at 320 tonnes per year against the 100 to 1,000 tonnes registration is flagged for tonnage-band ceiling proximity monitoring — a sustained upward trend past 800 tonnes per year would trigger the pre-planning workflow for a tonnage-band upgrade to the above-1,000 tonnes band with the associated incremental ECHA fee of EUR 8,000 and the incremental dossier data requirements.

Common reconciliation breakages

Five breakages recur across Indian specialty chemistry producers running the annual REACH cost accounting cycle, and each maps to a specific control failure that a statutory audit under CARO 2020 or a Board-level EU-market compliance review will surface.

• Consortium Letter of Access cost expensed to profit and loss instead of capitalised as an intangible asset. The largest and most common cost-treatment error. A producer paying EUR 60,000 to a consortium at registration for the LoA to the shared registration dossier treats the entire amount as a Section 37 revex — professional-services expense — in the year of payment, missing the identifiability and future-economic-benefits recognition tests under Ind AS 38 paragraph 21. The consequence is understated intangible asset carrying value, overstated current-year expense, understated future-year expense (no amortisation charge in subsequent years) and a misalignment between the substance’s REACH cost profile and the substance’s export-revenue profile. Reconciliation discipline: every one-time REACH registration cost component (SIEF fee, LoA fee, ECHA registration fee, dossier-preparation directly attributable cost) is capitalised at initial recognition into the Ind AS 38 intangible asset register per substance with the ECHA registration number as the register key, and the useful life determination is documented in the year of initial recognition with subsequent review each period.

• Useful life determination inconsistently applied across the substance portfolio without documented policy. A producer applying finite-10-year amortisation to some substances and indefinite-useful-life treatment to others without a documented policy anchored to substance-specific commercial and regulatory evidence creates a materiality and disclosure risk under Ind AS 38 paragraph 118 (disclosure of useful life determination method and rationale). A CARO 2020 auditor’s observation on inconsistent-application-without-policy is a common finding. Reconciliation discipline: the enterprise’s Ind AS 38 accounting policy for REACH registration intangible assets is documented in the accounting policy manual with the criteria for finite versus indefinite classification per substance, and the substance-level classification is annually reviewed with justification documented in the annual impairment test log.

• Ind AS 36 impairment test not performed annually for substances classified as indefinite useful life. Under Ind AS 36 paragraph 10, an intangible asset with indefinite useful life must be tested for impairment annually irrespective of any impairment indicator. A producer that classifies a substance’s REACH registration as indefinite useful life but does not conduct the annual impairment test creates a Companies Act 2013 statutory audit compliance gap and an ICFR (internal financial controls) deficiency. Reconciliation discipline: the annual impairment test log is a standing input to the year-end close cycle for every indefinite-useful-life substance, with the recoverable amount computation (higher of fair value less costs of disposal and value in use) documented per substance. The methodology framework for anchoring the impairment test log to the year-end close discipline is captured in Terra Insight’s reconciliation control plan template and the broader ICFR internal financial controls reconciliation walkthrough.

• Section 195 TDS deducted at treaty-nil-rate without Form 15CB certificate and DTAA-treaty-analysis documentation. A producer remitting the annual OR retainer to a Netherlands-based Only Representative and taking a treaty-nil-rate position under the make-available test without a Chartered Accountant’s Form 15CB certificate and without documented make-available-test analysis creates a Section 195 audit exposure. The Income-tax Department can, at a later audit, disallow the treaty-nil-rate position and demand Section 195 short-deduction with interest and penalty. Reconciliation discipline: every OR retainer remittance is supported by a current-year Tax Residency Certificate from the OR, a Form 10F filing, a Chartered Accountant Form 15CB certificate documenting the DTAA article invocation and the make-available test analysis, and Form 15CA filed with the tax authority before remittance. The record is retained for the standard limitation period under the Income-tax Act 1961.

• SVHC monitoring skipped, and downstream-user Article 33 notification obligation missed. The ECHA SVHC candidate list is updated bi-annually (typically June and December each year). Every addition triggers a review of whether any component of the producer’s substance portfolio now crosses the 0.1 percent weight by weight threshold at the article level. A producer that skips the monitoring — treating REACH compliance as a one-time registration event rather than an ongoing obligation — misses the Article 33 supply-chain notification window (45 days) and creates a REACH non-compliance exposure that can trigger ECHA enforcement action and downstream-EU-customer contractual breach claims. Reconciliation discipline: the SVHC monitoring log is a standing input to the year-end close cycle with each bi-annual ECHA candidate list update reviewed against the substance portfolio, and any Article 33 notification trigger flagged with the notification issuance date, the downstream-user recipient list and the notification content record. The reconciliation posture on coverage limits and human-error surfacing sits in the human errors detection envelope anchor.

How a reconciliation platform handles this

A purpose-built chemicals reconciliation platform ingests the producer’s per-substance REACH registration cost register with the ECHA registration number, tonnage band, SIEF fee, consortium LoA fee, ECHA registration fee and annual OR retainer per substance, holds the Ind AS 38 intangible asset register with the useful life determination and the annual amortisation schedule per substance, computes the annual amortisation charge and updates the carrying value each year, runs the annual impairment test log with the impairment-indicator assessment per substance, maintains the FEMA Form A2 remittance record with the Authorised Dealer bank reference and the Form 15CA / 15CB certificate reference per remittance, holds the Section 195 DTAA-treaty-analysis record with the Tax Residency Certificate and Form 10F reference per OR retainer payment, reconciles the Section 194J TDS deduction for Indian regulatory-consulting support to Form 26AS, tracks the bi-annual ECHA SVHC candidate list updates against the substance portfolio and surfaces any Article 33 supply-chain notification trigger, and produces the annual REACH reconciliation packet for the statutory audit and the Board’s EU-market compliance review. Standing dashboard controls surface any substance approaching the tonnage-band ceiling for pre-planning of the next-band upgrade, any indefinite-useful-life substance where the annual impairment test is overdue, any OR retainer remittance where the Tax Residency Certificate is expired, and any SVHC candidate list update requiring downstream-user Article 33 notification. Match-rate improvement of 51 to 88 percent on the per-substance registration cost register to the general-ledger intangible asset carrying value reconciliation, combined with an ISO 27001:2022 posture and DPDP Act 2023 aligned data handling for regulator-facing submissions, is what makes the platform an infrastructure investment for a Tier-1 Indian specialty chemistry producer running a multi-substance EU-registered portfolio — rather than a spreadsheet substitute that leaves the intangible-asset amortisation schedule, the impairment test log and the SVHC monitoring log as manual overheads on the CFO team. The commercial pillar for the chemicals sub-cluster is chemical reconciliation software India; the broader authority for the platform is reconciliation software India.

Cross-cluster bridges and where to read next

The REACH cost accounting cornerstone documented here anchors the Chemicals Wave 3 Theme 7 international-market-access cluster. The sibling walkthrough at REACH Only Representative annual retainer reconciliation for an Indian chemical exporter unpacks the annual OR retainer cycle in more granular operational detail — appointment agreement lifecycle, Tax Residency Certificate refresh, Form 15CA / 15CB annual cycle, and the reconciliation to the substance-level export volume register.

The Chemicals Wave 3 MSIHC-and-MoEFCC theme runs in parallel — a Tier-1 producer’s Indian plant compliance leg draws on off-site emergency plan MSIHC Rule 13 chemical plant cost for the District Collector-led Rule 13 off-site emergency plan, MoEFCC CTE and CTO clearance chemical plant cost accounting India for the pre-construction and post-commissioning environmental clearance cycle, EIA Notification 2006 Category A versus B chemical plant clearance for the Central versus State clearance mechanic, Consent to Operate CTO renewal chemical plant CPCB Red Orange for the CPCB colour-category renewal cadence, and MoEFCC consultancy EIA report cost capitalisation chemical expansion for the pre-operative expenditure capitalisation boundary.

The Wave 2 hazardous-chemicals cornerstone at MSIHC 1989 hazardous chemical reconciliation for India documents the monthly Schedule 1 chemical-wise inventory register mechanic against the column-3 isolated-storage and column-4 industrial-activity thresholds; the sibling walkthroughs at MSIHC Schedule 1 threshold tier classification for a chemical plant, Public Liability Insurance Act 1991 premium reconciliation for hazardous chemicals and Safety Data Sheet cost accounting for hazardous chemicals in India unpack the tier-classification, no-fault-liability cover and GHS-labelling-cost mechanics. The Wave 2 export cornerstone at chemical exporter Bill of Entry and IGST refund Section 16 reconciliation covers the LUT-versus-IGST-paid decision framework for the same EU-export leg.

Cross-cluster bridges: the Chemicals Wave 1 cornerstone at Rule 89(5) inverted duty refund specialty chemicals India documents the parallel Section 54(3) inverted-duty refund cycle for the domestic GST leg; the methodology framework — mapping each REACH registration event to a reconciliation surface, holding the intangible-asset amortisation schedule as a standing control, and building the annual impairment test log into the year-end close cycle — sits in reconciliation failure mode analysis and reconciliation playbook for monthly close. The statutory audit checklist that surfaces the intangible-asset-audit review, the CARO 2020 reporting on intangible assets and the Section 195 TDS audit trail sits in statutory audit reconciliation checklist India. The chemicals cluster hub indexes the full library.

The five FAQs below address the operational questions Indian specialty chemistry CFOs, regulatory-affairs leads and international-market-access owners ask most often when building a standing annual REACH cost accounting cycle against the five regulatory anchors — REACH Regulation (EC) No 1907/2006, Ind AS 38, Ind AS 36, Section 195 and Section 194J of the Income-tax Act 1961.

Terra Insight Editorial Team Reconciliation Infrastructure

Content authored by practitioners with experience at Amazon India, Intuit QuickBooks, and the Tata Group. Meet the team →

Published 24 July 2026

Domain expertise

TDS Reconciliation GST Input Credit Platform Settlements NACH Batch Matching Bank Reconciliation Form 26AS Matching ERP Integrations Enterprise Finance Ops

Reviewed by

NK

Navin Krishnan

Managing Director & Founder — Terra Insight

Ex Amazon India · Intuit QuickBooks · Tata nexarc

ISO 27001:2022 Patent Pending Incorporated 2024